Login

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Assets
Cash and cash equivalents
Restricted cash
Investments:
Held-to-maturity debt securities, at amortized cost (net of allowance for credit losses of $5 at June 30, 2024 and $125 at December 31, 2023)
Available-for-sale debt securities, at fair value (amortized cost $41,978 at June 30, 2024 and $58,516 at December 31, 2023)
Equity securities, at fair value (cost $2,000 in 2020)
Mortgage loans
Other invested assets
Total investments
Receivables (net of allowance for credit losses of $1,463 at March 31, 2023 and $1,488 at December 31, 2022)
Trade and other receivables (net of allowance for credit losses of $2,024 at June 30, 2024 and $1,802 at December 31, 2023)
Prepaid expenses, deposits and other assets
Lease right-of-use assets
Fixed assets (net of accumulated depreciation of $33,991 at June 30, 2024 and $26,272 at December 31, 2023)
Title plants
Goodwill
Trade names (net of accumulated amortization of $3,187 at December 31, 2020)
Assets held for disposal
Total assets
Liabilities and stockholders’ deficit
Accounts payable
Accrued expenses and other liabilities
Lease liabilities
Loan and Security Agreement, net of debt issuance costs and original issue discount
Loan from a related party
Liability for loss and loss adjustment expenses
Warrant liabilities
Sponsor Covered Shares liability
Liabilities held for disposal
Total liabilities
Stockholders’ deficit:
Preferred stock
Preferred Stock Series A
Preferred Stock Series A-2
Preferred Stock Series A-1
Preferred Stock Series A-2
Preferred Stock Series B
Preferred Stock Series C
Common stock, 0.0001 par value; 80,000,000 shares authorized at June 30, 2024; 14,074,805 and 13,524,203 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively
Total common stock, 0.0001 par value; 80,000,000 shares authorized at June 30, 2024; 14,074,805 and 13,524,203 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support